Connect with us


The new cannabis manual all consumers need to read



The book is aiming to give its readers a ‘big picture perspective’ of cannabis

A new e-book aims to tackle the myths and misconceptions around cannabis and arm consumers with the all the science-backed knowledge they need. 

Cannabis science firm, Global Cannabinoid Solutions (GCS) has announced the publication of its first consumer safety guide, The Canna-Manual.

Dubbed as a public education guide, the e-book brings together the latest scientific knowledge, education and peer-reviewed research to arm consumers with a ‘big picture perspective’ of cannabis. 

Less than one percent of British patients have legal access to cannabis leaving cancer patients, veterans with PTSD and grandparents living with chronic pain, criminals in the eyes of the law.

Through The Canna-Manual, GCS aims to highlight the societal implications that current UK legislation brings, and raise awareness of the science behind the plant and its unique relationship with humanity.

Author and GCS’ managing director Chris Tasker, who holds a Masters (MRes) in Cannabis medical research has conducted first-hand research to explore the therapeutic effects of cannabinoids and the endocannabinoid system in colorectal cancer and inflammatory bowel disease. 

He has supported the growth of informed cannabis debate across the UK, promoting cannabis education and drug law reform.

Alongside a team of scientists and consultants at GCS, he now works to steer early cannabis enterprise with their multidisciplinary understanding of cannabis and endocannabinoid medicine.

“Up until now, there has been a tremendous disconnect between science, industry, and society, resulting in an incoherent cannabis conversation,” writes Chris.

“This book aims to provide a reliable foundation of knowledge that helps readers understand the depth of the relationship between cannabis and humans. 

“With this, we hope to protect readers from the common myths and misconceptions around cannabis and continue to prepare the public for a wider discussion around cannabis and our treatment of drugs as a whole.”

A percentage of the proceeds from The Canna-Manual will be allocated to supporting patient prescriptions costs and the community. 

Chris commented: “This guide unifies world-leading cannabis knowledge and places it in the hands of consumers. 

“This prepares readers for the emergence of the cannabis industry outlining the very real challenges impacting people on the frontline.” 

GCS has also launched The Cannabis Crash Course e-book, an industry preparation guide to help professionals safely and effectively navigate the ever-changing cannabis sector.

The Canna-Manual and The Cannabis Crash Course are available on Amazon now.

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag


Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.